Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion type Assertion NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_head.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion description "[Thus, CD34 selection of PBPCs markedly reduces tumor contamination in multiple myeloma and provides effective hematopoietic support for patients receiving myeloablative therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion evidence source_evidence_literature NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion SIO_000772 7540888 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion wasDerivedFrom befree-20140225 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion wasGeneratedBy ECO_0000203 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.